此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

为面临植入式心律转复除颤器脉冲发生器更换的成年人提供决策支持

2026年8月14日 更新者:Ottawa Heart Institute Research Corporation

成人面临植入式心律转复除颤器脉冲发生器更换的决策支持评估:一项可行性研究

The implantable-cardioverter defibrillator (ICD) is a small medical device used to treat dangerously fast and potentially life-threatening heart rates. For patients at risk, the ICD can detect an abnormal rhythm and provide life-saving therapy by delivering a shock. ICD therapy has risks and benefits that should be weighed from each patient's perspective. An ICD battery needs to be surgically replaced 4 to 7 years to ensure ongoing function. At present, the majority of these batteries are automatically changed without eliciting patients' preferences. There is a need for a better way to engage with patients. Patients want to be involved in their healthcare decisions, yet more than half of patients with an ICD do not know that ICD replacement is optional. To ensure that patients are receiving treatment that they value and want, members of the interprofessional team should ensure that treatment decisions align with patients' expectations, values and preferences. This rests on the principle of shared decision making in which members of the healthcare team and patients deliberate together to arrive at a decision which best reflects the preferences and values of the patient. To facilitate the achievement of this goal, a patient decision aid (PDA) can be used. As a result, the investigators developed PDA for ICD replacement. The purpose of this feasibility trial is to collect preliminary data to test the feasibility of conducting a larger trial, and to evaluate the PDA for its acceptability and ease of use. Eligible and consented participants facing ICD replacement will be randomized to receive the decision aid or to usual care. The investigators will assess if this decision aid can improve participants' knowledge on ICD therapy and the replacement surgery, increase patients' perceived involvement in the decision, and determine whether their actual choice reflects their personal values.

研究概览

详细说明

Sudden cardiac death (SCD) due to a ventricular arrhythmia is a serious cause of cardiovascular death in Canada. The implantable cardioverter defibrillator (ICD) can reduce the incidence of SCD in high-risk patients by delivering an internal shock to restore a normal rhythm. The life expectancy of an ICD generator is estimated between four and seven years, and must be surgically replaced to ensure ongoing function. Implantable cardioverter-defibrillator (ICD) replacement is becoming increasingly common constituting nearly 40% of all ICD procedures. For the most part, ICDs are automatically replaced. With every ICD replacement, the net benefit of continued ICD therapy should be assessed individually in view of the procedural risks, inappropriate shocks, psychological risks, changes in health status, and the potential for harm and suffering at end-of-life. Some studies have shown that the mortality benefit of an ICD attenuates with advancing age and comorbidities.

There are many legitimate reasons for declining ICD generator replacement. The chronic nature of a cardiac condition and/or the diagnosis of a life-limiting disease since initial implantation may compel a patient to reconsider their health care goals from supporting quantity of life, to prioritizing one of quality. This is an important distinction as the ICD can prolong the dying process by delivering shock(s) which can result in pain and discomfort for the patient, and helplessness for witnesses. Other patients have reported psychological distress, while others report only truly understanding the effects of living with an ICD after receiving one, possibly leading to changes in treatment preference when they are faced with the decision to replace. Also, the replacement procedure includes a substantially greater risk for infection and reoperation as compared to the initial implantation.

These complexities warrant decision support to prepare patients to make decisions. Yet, no means exists to support patients' decision-making in the context of ICD replacement. A decision support intervention (including a patient decision aid with decision coaching) was developed using a user-centered design with various stakeholders and potential end-users, which could moderate treatment related uncertainty and prepare patients to make high quality decisions that are informed and based on their personal preferences and values.

Objectives:

  1. Conduct a pilot randomized controlled trial (RCT) to determine the feasibility of conducting a larger trial.
  2. To determine the effect of the decision support intervention for adults faced with ICD replacement on attributes of decision quality and decision-making processes

研究类型

介入性

注册 (实际的)

30

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Ontario
      • Ottawa、Ontario、加拿大、K1Y 4W7
        • University of Ottawa Heart Institute

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • ICD battery nearing depletion or at elective replacement indicator
  • Able to speak and read in English
  • Able to provide informed consent; or if incapable of providing informed consent, can be obtained by the patient's appointed substitute decision-maker or power of attorney for personal care.

Exclusion Criteria:

  • Participants and/or substitute decision maker unable to understand the patient decision aid or decision coaching session due to language barrier or visual impairment
  • Participants with cardiac resynchronization therapy (CRT) or participants eligible for an upgrade to CRT.
  • Participants with conduction system disease who are pacemaker dependent

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Decision support

The decision support intervention includes a patient decision and a decision coaching session. The patient decision aid includes a summary about the ICD's function, and the risks and benefits (including probabilities) associated with the option of replacing or not replacing the ICD. The decision coaching session will be led by a trained, non-directive decision coach who will provide support that aims to develop patients' skills in thinking about the options, assess their values associated with each option, and prepare them to discuss the decision in a consultation with their physician. The final decision, whether to replace or not replace the ICD, will be made with their treating physician (e.g., cardiologist, electrophysiologist).

The decision support intervention includes a patient decision and a decision coaching session. The patient decision aid includes a summary about the ICD's function, and the risks and benefits (including probabilities) associated with the option of replacing or not replacing the ICD. The decision coaching session will be led by a trained, non-directive decision coach who will provide support that aims to develop patients' skills in thinking about the options, assess their values associated with each option, and prepare them to discuss the decision in a consultation with their physician. The final decision, whether to replace or not replace the ICD, will be made with their treating physician (e.g., cardiologist, electrophysiologist).

无干预:Usual care

The control group will not receive the decision support intervention prior to consultation with the physician.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Pilot RCT (Feasibility Measure): Participant Referral/Recruitment Rate.
大体时间:Baseline to 12 months
Baseline to 12 months
Pilot RCT (Feasibility Measure): Completion of Decision Support Intervention
大体时间:Baseline to 6 months

In this feasibility RCT, the feasibility regarding key processes to the success of a larger trial will be assessed. The investigators will descriptively collect the rate of participants who complete the decision support intervention.

Baseline to 6 months
Percentage of Participants With Missing Questionnaires
大体时间:Baseline to 6 months

The percentage of participants with missing questionnaire data is reported.

Baseline to 6 months

次要结果测量

结果测量
措施说明
大体时间
Knowledge
大体时间:Measured at 2-4 week Follow Up

The investigators developed a knowledge test based on the content of the patient decision aid. It was endorsed for validity by the Patient Decision Aid (PtDA) development team using a standardized template in the form of true or false questions. There are six questions meant to assess a patient's understanding of their heart condition, treatment options, and risks and benefits of each option. Reported scores are the mean percentage of correctly answered questions from the knowledge based test.

Measured at 2-4 week Follow Up
Decisional Conflict
大体时间:1 month, 6 months, 12 months follow-up

The Decisional Conflict Scale measures a person's perception of the difficulty in making a decision, the extent to which they feel uncertain about treatment options, are knowledgeable about the risks and benefits of options, clear about personal values, and supported in decision making. The scale has good test-retest reliability (Cronbach's alpha coefficients > 0.78) and predictive validity.

The scores for each item range from 0-4. The scores for all items are summed, then divided by 16 and multiplied by 25. Total scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).

Scores lower than 25 are associated with decision implementation and scores higher than 37.5 are associated with delayed decisions.

1 month, 6 months, 12 months follow-up
Preferred Option
大体时间:Assessed at 2-4 weeks

Preferred option will be measured by asking patients whether they prefer to have their ICD's pulse generator replaced, not replaced, or whether they are unsure using the 15-point Choice Predisposition Scale that demonstrates a patient's inclination toward a given option. This scale has a test-retest coefficient >0.90.

Score scale 1-15 with lower scores indicating a preference to not replacing the ICD, and high scores toward replacing.

Assessed at 2-4 weeks
Perceptions of Involvement in Decision-making at 6Months
大体时间:at 6 month follow up

This will be measured using a modified version of Strull, Lo, & Charles's (1984) role in decision-making survey. Five statements rest along the continuum of how decisions can be made between patients and providers. Participants must select the statement that best represents their perceived involvement in the final decision.

Results are cumulative across timepoints.

at 6 month follow up
Perceptions of Involvement in Decision-making at 12Months
大体时间:at 12 month follow up

This will be measured using a modified version of Strull, Lo, & Charles's (1984) role in decision-making survey. Five statements rest along the continuum of how decisions can be made between patients and providers. Participants must select the statement that best represents their perceived involvement in the final decision.

Results are cumulative across timepoints.

at 12 month follow up
The Medical Outcomes Trust Short Form (SF-36v2)
大体时间:Baseline visit intervention and usual care groups

The SF-36 is a reliable and valid generic health related quality of life scale (HRQL) comprised of 36 items. Associations between HRQL and decision choice will be made.

Score ranges from 0 to 100. Higher scores indicate better perception of health.

Baseline visit intervention and usual care groups
Acceptability and Usability of Patient Decision Aid
大体时间:1 month; intervention group only

Intervention group participants will be asked common acceptability and usability questions extensively used for evaluating PtDAs during development (Barry, Cherkin, Chang, Fowler, & Skates, 1997; Kushniruk & Patel, 2004; O'Connor & Cranney, 2002).

Results are reported as the number of participants selecting the highest acceptability for each category with the most positive answer in parenthesis in the row title.

1 month; intervention group only
Participant Satisfaction With Decision Coaching
大体时间:1 month; intervention group only

Patients' satisfaction with decision coaching will be measured using the Genetic Counseling Satisfaction Scale and perceptions of decision coach neutrality (Schwalm, Stacey, Pericak, & Natarajan, 2012; Tercyak, Johnson, Roberts, & Cruz, 2001). This scale has face validity and a reliability coefficient of alpha 0.80 to 0.90 in genetic counselling contexts with adults.

Results are reported as number of participants that rated the highest satisfaction for each question, with the most positive response in parentheses in the row name.

1 month; intervention group only

其他结果措施

结果测量
措施说明
大体时间
Actual Choice at 6months
大体时间:6 month followup; intervention and usual care groups

The number of participants who chose to accept ICD replacement, or decline ICD replacement. Only participants that were required to make a final decision and procedure dates occurred at the 6 month timeline.

6 month followup; intervention and usual care groups
Actual Choice at 12months
大体时间:12 month followup; intervention and usual care groups

The number of participants who chose to accept ICD replacement or decline ICD replacement. Results include only those participants required to make a final decision, with procedure dates up to the 12month follow-up. Note that the results at 12months include those at 6months as cumulative data.

12 month followup; intervention and usual care groups
Survival
大体时间:6 months, 12 months; intervention and usual care groups14

The number of participants who are alive or dead at 6 months and 12months.

6 months, 12 months; intervention and usual care groups14

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Dawn Stacey, RN, PhD、University of Ottawa; Ottawa Hospital Research Institute

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2016年4月1日

初级完成 (实际的)

2018年4月1日

研究完成 (实际的)

2018年10月1日

研究注册日期

首次提交

2016年1月15日

首先提交符合 QC 标准的

2016年1月26日

首次发布 (估计的)

2016年1月29日

研究记录更新

最后更新发布 (实际的)

2026年11月9日

上次提交的符合 QC 标准的更新

2026年8月14日

最后验证

2022年4月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅